Liminal BioSciences Inc.

NASDAQ: LMNL · Real-Time Price · USD
8.50
0.01 (0.12%)
At close: Sep 25, 2023, 9:59 PM

Liminal BioSciences Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
401K 643K
Cost of Revenue
n/a n/a
Gross Profit
401K 643K
Operating Income
-32.98M -49.56M
Interest Income
n/a n/a
Pretax Income
-29.44M -44.95M
Net Income
-28.92M -45.06M
Selling & General & Admin
17.87M 31.93M
Research & Development
15.3M 18.35M
Other Expenses
-212K 75K
Operating Expenses
33.16M 50.27M
Interest Expense
1.08M 6.33M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
33.16M 50.27M
Income Tax Expense
-525K 118K
Shares Outstanding (Basic)
84.6K 84.6K
Shares Outstanding (Diluted)
3.1M 3.02M
EPS (Basic)
-341.8 -532.66
EPS (Diluted)
-9.32 -14.94
EBITDA
-31.86M -45.21M
EBIT
-24.3M -34.12M
Depreciation & Amortization
1.12M 4.34M